Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT01267253Phase 2Completed
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
PrincipalinvestigatorStart date: 2011-04-04
NCT01167712Phase 3Active Not Recruiting
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more
PrincipalinvestigatorStart date: 2010-09-27
NCT00979992Phase 2Completed
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma
PrincipalinvestigatorStart date: 2010-04-19

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sharon Manne

Rutgers Cancer Institute of New Jersey

Related
5 trials

Shared therapeutic areas:

Stage IIA Fallopian Tube Cancer AJCC v6 and v7Stage IIA Ovarian Cancer AJCC V6 and v7Stage IIB Fallopian Tube Cancer AJCC v6 and v7+15 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Shannon Westin

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Primary Peritoneal Serous AdenocarcinomaRecurrent Ovarian CarcinomaStage IIIA Fallopian Tube Cancer AJCC v7+11 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Shannon N Westin

M.D. Anderson Cancer Center

Related
7 trials

Shared therapeutic areas:

Recurrent Ovarian CarcinomaStage IIIA Fallopian Tube Cancer AJCC v7Stage IIIA Ovarian Cancer AJCC v6 and v7+10 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Evanthia Galanis, MD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+9 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Emese Zsiros

Roswell Park Cancer Institute

Related
6 trials

Shared therapeutic areas:

Recurrent Ovarian CarcinomaOvarian Clear Cell AdenocarcinomaOvarian Serous Adenocarcinoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Jose A Rauh-Hain

M.D. Anderson Cancer Center

Related
3 trials

Shared therapeutic areas:

Fallopian Tube Transitional Cell CarcinomaOvarian Clear Cell AdenocarcinomaOvarian Endometrioid Adenocarcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Matthew S. Block, M.D., Ph.D.

Mayo Clinic

Related
4 trials

Shared therapeutic areas:

Recurrent Ovarian CarcinomaFallopian Tube Transitional Cell CarcinomaOvarian Endometrioid Adenocarcinoma+3 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Jermaine Coward

Integrated Haematology and Oncology Network

Related
2 trials

Shared therapeutic areas:

Ovarian Clear Cell AdenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Mucinous Adenocarcinoma
Similarity Score2%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Recurrent Cervical CarcinomaCervical AdenocarcinomaRecurrent Ovarian Carcinoma
Similarity Score2%

D. McMeekin

Gynecologic Oncology Group

Related
4 trials

Shared therapeutic areas:

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaRecurrent Cervical Carcinoma

Worked with same sponsors:

Gynecologic Oncology GroupNational Cancer Institute (NCI)
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01267253Phase 2PrincipalInvestigator

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
Completed
NCT01167712Phase 3PrincipalInvestigator

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more
Active Not Recruiting
NCT00979992Phase 2PrincipalInvestigator

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma
Completed

All 3 trials loaded